The dysregulation of the immune response between microbial-derived antigens and the immune response to pathogens in the gut can lead to human inflammatory bowel disease (IBD), which is partly characterized by an abnormal CD4+ T-cell response. This evidence concerns the gene CD4 and inflammatory bowel disease.